Header Ads

Central Drug Agency Seeks Clarification From Glenmark On Its COVID Drug

July 20, 2020 ,
The Drugs Controller General of India (DCGI) has asked for a clarification from Glenmark Pharmaceuticals regarding its alleged "false claims" on the utilisation of anti-viral FabiFlu (favipiravir) on...

from NDTV News - India-news https://ift.tt/3jjsiDu

Post a Comment

No comments

Subscribe to: Post Comments ( Atom )
Powered by Blogger.